Targeted Therapies in Metastatic NSCLC: Liquid Biopsies as a New Option in Patient Care and Day-to-Day Management

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Targeted Therapies in Metastatic NSCLC: Liquid Biopsies as a New Option in Patient Care and Day-to-Day Management

By GRACE FEATURING Charu Aggarwal

616 views

July 22, 2019

0 Comments

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Feat. W. Iams

35:40

Balazs Halmos

Year in Review: Lung Cancer

11:07

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical…

Feat. J. West

20:52

Total Health

Diagnostics in Lung Cancer: A Comprehensive Discussion - Best of Lun…

Feat. T. Boyle

26:21

Memorial Sloan Kettering Cancer Center

NSCLC & Targeted Therapy: A Brief Overview and Update in the Met…

Feat. M. Hwang

14:49

Vivek Subbiah

Year in Review: Precision Medicine

23:32

2023 West Oncology Conference

2023 Updates on Neoadjuvant and Adjuvant NSCLC

Feat. M. Johnson

17:34

ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez

54:26

Yale Cancer Center

Year in Review: Progress in NSCLC Treatment

Feat. R. Herbst

08:30

Insights from 2023 ESMO Annual Meeting

PAPILLON Study - Amivantamab + Chemo vs. Chemo as 1L Treatment in EG…

Feat. N. Girard

20:27

Yale Cancer Center

Progress in the Treatment of NSCLC

Feat. R. Herbst

26:42

Total Health

ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 AS…

Feat. J. Bauman

08:15

ecancer

ESMO 2023 Summary: "Highlights From Recent NSCLC Trials"

Feat. B. Gyawali

23:29

2023 Evolution Conference

IO and Targeted Treatment for mNSCLC

Feat. M. Mooradian

07:38

GRACE

How Does PD-L1 Score Affect Treatment Options for NSCLC

Feat. S. Patel, T. Leal, P. Iyengar, A. Desai, C. Kim, J. Rotow

03:22

ecancer

WCLC 2023 Insights: "Phase 3 FLAURA2 Study - Osimertinib + Chem…

Feat. P. Janne

04:31

Integrity Continuing Education

Neoadjuvant and Adjuvant Treatment in Early Stage NSCLC: Options Are…

Feat. J. Gainor, J. Sands

28:04

OncoAlert

Current Controversies in NSCLC Treatment

Feat. J. West

13:21

Yale Cancer Center

Navigating the Terrain: Recent Treatment Strategies for EGFRm Advanc…

Feat. A. Nassar

16:17

Timothy Burns

Login

Login

Join VuMedi

Targeted Therapies in Metastatic NSCLC: Liquid Biopsies as a New Option in Patient Care and Day-to-Day Management

Related Content